Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genome-based vaccines.

Andreas Knaust1, Matthias Frosch

  • 1Institut für Hygiene und Mikrobiologie, Universität Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany. aknaust@hygiene.uni-wuerzburg.de

International Journal of Medical Microbiology : IJMM
|November 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increase in imported mupirocin-resistant <i>Staphylococcus aureus</i> from the tropics and subtropics: trends in Berlin from 2018 to 2025.

New microbes and new infections·2026
Same author

Prospective single-center study of health-related quality of life after COVID-19 in ICU and non-ICU patients.

Scientific reports·2023
Same author

Viral infections in hospitalized children in Germany during the COVID-19 pandemic: Association with non-pharmaceutical interventions.

Frontiers in pediatrics·2022
Same author

Successful control of Candida auris transmission in a German COVID-19 intensive care unit.

Mycoses·2022
Same author

[Significance of the doctorate in scientific medical education].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2017
Same author

Comparative Genome Sequencing Reveals Within-Host Genetic Changes in Neisseria meningitidis during Invasive Disease.

PloS one·2017
Same journal

Successful treatment of rare non-dermatophyte onychomycosis caused by Chaetomium spp. with oral fluconazole and topical terbinafine combination - A case report from Indonesia and literature review.

International journal of medical microbiology : IJMM·2026
Same journal

Toxin gene truncation via IS1132 in non-toxigenic toxin gene-bearing (NTTB) Corynebacterium diphtheriae.

International journal of medical microbiology : IJMM·2026
Same journal

Gain-of-function mutation in the sensor kinase CpxS modulates the antimicrobial resistance and virulence of Pseudomonas aeruginosa.

International journal of medical microbiology : IJMM·2026
Same journal

Mycobacterium tuberculosis identification and antibiotic resistance gene profiling using nanopore sequencing: A new approach for tailoring more effective treatments for patients.

International journal of medical microbiology : IJMM·2026
Same journal

Epidemiology and population structure of Acinetobacter baumannii outbreak in a COVID-19 concentration center.

International journal of medical microbiology : IJMM·2026
Same journal

Herpes simplex virus 1 UL2 protein inhibits RIG-I-like receptor pathway-induced IFN-β activity by disrupting IRF3 activation.

International journal of medical microbiology : IJMM·2026
See all related articles

Genomic data aids in identifying vaccine targets for difficult-to-target bacterial pathogens. This approach helps develop new vaccines against infections caused by bacteria like Neisseria meningitidis and Streptococcus pneumoniae.

Area of Science:

  • Microbiology
  • Immunology
  • Genomics

Background:

  • Vaccines are crucial for preventing bacterial and viral infections.
  • Effective vaccines are not yet available for several significant bacterial pathogens.
  • Complete genome sequencing is increasingly available for bacterial pathogens.

Purpose of the Study:

  • To summarize current genomic approaches for identifying vaccine targets.
  • To identify antigenic proteins for vaccine development against key bacterial pathogens.

Main Methods:

  • Utilizing complete genome sequences for comprehensive screenings.
  • Bioinformatic analysis to identify potential antigenic proteins.

Main Results:

  • Genomic approaches enable the identification of vaccine targets.

Related Experiment Videos

  • Specific antigenic proteins can be identified through genome analysis.

    • Conclusions:

    • Genomic data provides a powerful tool for vaccine development against bacterial pathogens.
    • This strategy can accelerate the creation of novel vaccines for Neisseria meningitidis, Streptococcus pneumoniae, Staphylococcus aureus, and Chlamydia pneumoniae.